Study finds cardiovascular risk score improves after one year of semaglutide use in patients with overweight and obesity
New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use. The study ...
May 19, 2023
0
20